Substance Use & Abuse in Pregnancy Janet L. Mitchell, M.D., M.P.H., F.A.C.O.G. Consultant on Women’s Health Addiction Research & Treatment Corporation.

Slides:



Advertisements
Similar presentations
Perinatal Substance Abuse: Methadone Maintenance Treatment Presented by: Toni Royer, MHS, NCGC, CAC-AD Executive Director, ARS Pantops Clinic.
Advertisements

Background Infant mortality is defined by the CDC as the death of an infant less than one year old. This is a critical indicator of the well being of a.
Chapter 12 Maternal and Fetal Nutrition Debbie Hogan RN.
13 Principles of Effective Addictions Treatment
Effective Risk Management Strategies in Outpatient Methadone Treatment: Clinical Guidelines and Liability Prevention Curriculum Module 9 Special Populations.
IMPACT OF SUBSTANCE ABUSE ON THE MOTHER AND FETUS Siva Thiagarajah, M.D. Gary D. Helmbrecht, M.D. Prenatal Diagnosis Center Charlottesville, VA.
Moms on Meds Substance Abuse During Pregnancy: Jennifer Anderson Maddron, M.D.
SHARED QUALITY INITIATIVES IN OBSTETRICAL CARE IN PHILADELPHIA GUIDELINES FOR DRUG SCREENING IN OBSTETRICS Dimitrios S Mastrogiannis MD PhD MBA FACOG Director.
Pharmacological Treatment of Opioid Dependence during Pregnancy: Methadone and Buprenorphine Overview Karol Kaltenbach, PhD Maternal Addiction Treatment.
 Discuss why pregnant adolescents are considered high risk  Special Considerations in regards to  Use of force  Restraints  Transportation  Substance.
Interconception Education and Counseling: Strategies from Florida Presented by: Betsy Wood, BSN, MPH Infant, Maternal & Reproductive Health Unit Florida.
Antenatal Care (ANC): Overview
The costs and effectiveness of substance abuse treatment programs for pregnant women Marilyn Daley, Ph.D. Conference on Harm Reduction Strategies in Uzbekistan.
Preventing Infant Mortality: What We Know, What We Don’t, and What You Can Do Tom Ivester, MD, MPH UNC School of Medicine Division of Maternal Fetal Medicine.
A Brief Office Intervention for Alcohol Abuse F. David Schneider, MD, MSPH University of Texas Health Science Center at San Antonio.
John R. Kasich, Governor Tracy J. Plouck, Director Andrea Boxill, Deputy Director Andrea Boxill, Deputy Director Governor’s Cabinet Opiate Action Team.
Chapter Objectives Define maternal, infant, and child health.
Drugs and Crime Policy. Drug use and crime ► Psychoactive drugs: alter conscious awareness or perception ► Psychological dependency: person craves a drug.
Best Start - Prenatal Education Program Prenatal Care.
Linda Chamberlain, PhD MPH IPV and Sexually Transmitted Infections/HIV MENU Overview Regional and Local Data The Impact of IPV on Women’s Health IPV and.
Copyright © 2008 Delmar. All rights reserved. Chapter 22 Maternal and Child Populations.
1 NATIONAL CERTIFICATION EXAMINATION FOR ADDICTION COUNSELORS A Test Preparation Course Taken from the Handbook for Candidates.
Using FIMR and PPOR to Identify Strategies for Infant Survival in Baltimore Meena Abraham, M.P.H. Baltimore City Perinatal Systems Review MedChi, The Maryland.
Smoking Cessation for Pregnancy and Beyond: Virtual Clinic Companion Slides Catherine A. Powers, EdD, LSW PACE – Tobacco Prevention and Cessation Education.
SUBSTANCE USE DISORDERS GENERAL METHODS OF TREATMENT Inpatient Detoxification and Rehabilitation Outpatient Individual, Couple, or Family Counseling Self-help.
Pregnancy And Lactation Copyright 2005 Wadsworth Group, a division of Thomson Learning Life Cycle Nutrition.
Mitigating Risks of Substance Exposed Infants and Their Families Dixie L. Morgese, BA, CAP, ICADC.
Malformation of Extremities Malformation of Extremities.
Substance Exposed Newborns and their Families Dixie L. Morgese, BA, CAP, ICADC.
Instructor: Jose Davila
Perinatal Health: From a women’s health lifespan perspective Diana Cheng, M.D. Medical Director, Women’s Health Center for Maternal and Child Health 1.
Current Trends In Identifying And Treating Newborns With Withdrawal Syndromes 6/24/2010.
 John McCarthy, M.D.  Executive/Medical Director, Bi-Valley Medical Clinic, Sacramento.
Pregnancy and Drug Abuse Eva Janecek-Rucker. Learning Objectives 1.To develop a knowledge base of the effects of substances of abuse (e.g., alcohol, cocaine,
Module IV: Identification of Patients for Buprenorphine Treatment BUPRENORPHINE TREATMENT: A Training For Multidisciplinary Addiction Professionals.
Drugs An overview.
Chapter 16 Addictive Disorders. Abuse  Use of a substance that falls outside of medical necessity or social acceptance resulting in adverse effects to.
Treating Pregnant Opioid Dependent Women: Examining Buprenorphine and Methadone Hendrée E. Jones, Ph.D. Associate Professor Department of Psychiatry and.
A Clinical Outcome Study of Meth Exposed Infants Rizwan Z, Shah, M.D., FAAP Blank Children’s Hospital Des Moines, Iowa, USA.
Chapter 15: Substance-Related Disorders and Addictive Behaviors Copyright © 2012, 2007 Mosby, Inc., an affiliate of Elsevier Inc. All rights reserved.
Psychoactive Drug States  Human drug use has occurred for millenia  Psychoactive drugs: chemicals that affect mental processes and behavior by their.
Substance abuse. Substance abuse, dependence, withdrawal, tolerance, and demographics Substance abuse, dependence, withdrawal, tolerance, and demographics.
Incorporating Preconception Health into MCH Services
Special patient groups Module 5. Introduction Worldwide, the majority of people in substitute treatment are men between Even they do not form a.
TREATMENT OF SUBSTANCE USE DISORDERS TX myths 1. Nothing works 2. One approach is superior to all others (“one true light” tradition) 3. All treatment.
Don Teater MD Medical Advisor National Safety Council Itasca, IL Medical Provider Behavioral Health Group Asheville, NC Medical Provider Meridian Behavioral.
Module IV - Identification of Patients for Buprenorphine Treatment BUPRENORPHINE TREATMENT: A TRAINING FOR MULTIDISCIPLINARY ADDICTION PROFESSIONALS.
Elizabeth E. Krans, MD, MSc Assistant Professor, University of Pittsburgh Magee-Womens Research Institute Department of Obstetrics, Gynecology and Reproductive.
Neonatal Abstinence Syndrome
ANTENATAL CARE. Definition  Systematic supervision or care of a woman during pregnancy.  Also called prenatal care.
SUBSTANCE ABUSE prevention
Specific issues in drug use and pregnancy. Pregnant women who use drugs (RCOG, 2010) One of the challenges for pregnant women who use drugs is that they.
Drugs An overview. Psychoactive Drugs Chemicals that affect our nervous systems; and, as a result, may alter consciousness and awareness, influence how.
Substance Exposed Newborns: Addressing Substance Use Disorder
First Antenatal Assessment
Timby/Smith: Introductory Medical-Surgical Nursing, 11/e
Opioid Use Disorder and pregnancy seminar
Substance Abuse During Pregnancy: The Littlest Victims
Drug Abuse and Pregnancy
Screening and Referral
Neonatal Abstinence Syndrome: An emerging issue for Part C systems?
The Burden of Tobacco Use
Alcohol Consumption During Pregnancy
Presented by J. Arzaga, MSN, RN
Substance-Related and Addictive Disorders
First Antenatal Assessment
Brief Interview & Referral for Opioid Use Disorder Script
BoRN ADDICTED: Neonatal Abstinence syndrome
ADDICTION
PSYCHOPATHOLOGY OF CHILDREN AND FAMILY
Presentation transcript:

Substance Use & Abuse in Pregnancy Janet L. Mitchell, M.D., M.P.H., F.A.C.O.G. Consultant on Women’s Health Addiction Research & Treatment Corporation Brooklyn, NY

"THE ALCOHOL OF GREAT BRITAIN AND TENNESSEE AND THE TOBACCO OF KENTUCKY UNDOUBTEDLY CREATE GREATER RATES OF MORBIDITY AND DEATH THAN THE POPPY SEED OF TURKEY AND MEXICO” BLINICK, ET AL., DRUG ADDICTION IN PREGNANCY AND THE NEONATE AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY VOL. 125, NO. 2, 1976

Harlem Hospital’s Special Prenatal Program for Chemically Dependent Women 1200 Pregnancies between % were HIV infected, 50% for those with a hx of IDU 4%  21 years of age - primary drug of use marijuana 80% listed crack and/or cocaine as their primary drug of choice Avg # of drugs used 3.5 Higher rates of HCV then HBV

ADDICTION Polydrug Abuse Poor Nutritional Status STD's Hepatitis HIV Infection Other Medical Problems

ADDICTION and PREGNANCY Poor Dates Late Registration Inadequate Follow-up

ADDICTION and PREGNANCY MATERNAL CONCERNS Poor Pregnancy Self-image Low Tolerance For Pain Poor Bonding Poor Parenting Skills

ADDICTION FETAL/NEONATAL CONCERNS Low Birth Weight Teratogenicity (Congenital Anomalies) SIDS Spontaneous Abortions Abstinence Syndromes Future Development

RELAPSING ADDICTION IS A CHRONIC RELAPSING, MEDICAL DISEASE !!

ALCOHOL CNS Depressant Known Teratogen Psychological and Physiological Dependence

OTHER CNS DEPRESSANTS Barbiturates Benzodiazepines Methaqualone

COCAINE CNS Stimulant Psychological Dependence ? Physiological Dependence ? Neonatal Abstinence Syndrome

OTHER CNS STIMULANTS Amphetamines ‘Ice’ Diet Pills Nicotine Caffeine

COCAINE MATERNAL COMPLICATION Abruptio Placenta Preterm and/or Precipitous Labor Pre-eclamptic Like Syndrome Cardio-pulmonary problems Seizures

COCAINE FETAL/NEONATAL COMPLICATION Low Birth Weight Seizures Intracranial Hemorrhage ? Neonatal Abstinence Syndrome Not a Teratogen

OPIOIDS CNS Euphoria Not a Teratogen Psychological and Physiological Dependence Well Documented Neonatal Abstinence

METHADONE MAINTENANCE IS THE TREATMENT OF CHOICE DURING PREGNANCY!!

METHADONE and PREGNANCY MATERNAL CONCERNS Inappropriate Medical Withdrawal Inadequate Dosage Chronic Constipation Pain Management

METHADONE and PREGNANCY FETAL/NEONATAL CONCERNS Altered Antepartum Testing Neonatal Abstinence Syndrome

METHADONE MAINTENANCE IS THE TREATMENT OF CHOICE DURING PREGNANCY!!

RELAPSING ADDICTION IS A CHRONIC RELAPSING, MEDICAL DISEASE !!

CONCEPTS TREATMENT READINESS MOTIVATION TO TREATMENT

DRUG DEPENDENCY AS DESCRIBED BY THE WORLD HEALTH ORGANIZATION (WHO): “A BEHAVIORAL PATTERN IN WHICH THE USE OF A GIVEN PSYCHOACTIVE DRUG IS GIVEN A SHARPLY HIGHER PRIORITY OVER OTHER BEHAVIORS WHICH ONCE HAD A SIGNIFICANTLY HIGHER VALUE” WHO, 1982

STAGES TO SUCCESSFUL TREATMENT DENIAL NEGOTIATION ACCEPTANCE

PRENATAL INTAKE PROTOCOL Complete history, especially psychosocial & drug use Complete physical examination focusing on the multiple medical programs Routine prenatal bloods + hepatitis screen for B & C Tuberculin test Counseling for HIV with strong recommendation for testing Social service referral Referral to therapeutic drug program Methadone maintenance for opiod addiction Establish rules, requirements and goals with patient and significant others

PRENATAL FOLLOW-UP PROTOCOL More frequent visits to identify medical and psychosocial problems early Random urine toxicologies Order and repeat appropriate tests as necessary Establish an ongoing relationship with the patient’s therapeutic drug program Establish an ongoing relationship with patient’s significant other(s) Began to discuss contraceptive methods

LABOR AND DELIVERY PROTOCOLS Complete history and physical, especially recent drug history Repeat hepatitis screens and serological test for syphilis Urine toxicology Alert pediatric and nursing staff Alert social service Pain management as appropriate Method of delivery dependent on obstetrical indications only

POST PARTUM PROTOCOL Encourage continuation in a therapeutic drug program Encourage use of an appropriate contraceptive method Breastfeeding not contraindicated in methadone maintained women

RELAPSING ADDICTION IS A CHRONIC RELAPSING, MEDICAL DISEASE !!

TREATMENT IMPROVEMENT PROTOCALS (TIPS) FOR PREGNANT, SUBSTANCE-USING WOMEN Chair: Janet L Mitchell, MD, MPH, FACOG The Centers for Substance Abuse Treatment (CSAT) Division for State Programs Substance Abuse and Mental Health Services Administration SAMSA